Infectious Disease Control
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...
2021-05-18 11:50
3119
AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community
The "AIforCOVID Imaging Archive" platform enables the sharing of radiographic images from COVID-19 patients and development of leading-edge Artificial Intelligence-based methods for predicting clinical developments of the disease caused by SARS-CoV-2. The platform has been promoted and implement...
2021-05-18 04:44
1676
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines
PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...
2021-05-17 20:54
2428
The Kare Lab Launches Travel Protect Kit as Travel under New Normal Resumes in 2021
HONG KONG, May 17, 2021 /PRNewswire/ -- The Kare Lab, a leading supplier in providing medical-grade protective gears to leading institutes and hospitals across the APAC, has launched a new Travel Protect Kit for worldwide travelers as vaccines are being rolled out and the world looks to resume tr...
2021-05-17 13:26
3306
CGTN: True Colors Are shown in Crisis
BEIJING, May 15, 2021 /PRNewswire/ -- Crises are an unavoidable part of human
history. And the response to a crisis can make a difference in a country's
development.
2021-05-15 00:29
5324
China's Leading Big Data Expo to Start Online Show on May 20
GUIYANG, China, May 14, 2021 /PRNewswire/ -- 2021 China International Big Data
Industry Expo (CIBDIE), the country's leading big data expo, will be held in
southwestChina's Guiyang City from May 26 to 28.
2021-05-14 13:56
2515
Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO
TOKYO, May 14, 2021 /PRNewswire/ -- As the world joins together to fight the ongoing battle against the COVID-19 pandemic, Terumo Corporation (TSE: 4543) has announced that the Terumo Group companies will collectively donateUSD 1 million in cash to support the COVID-19 Solidarity Response Fund fo...
2021-05-14 09:05
6423
Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19
Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 13, 2021 /PRNewswire/ -- APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the ...
2021-05-13 00:48
3055
Zymo Research Releases Open-Source Bioinformatics Pipeline for SARS-CoV-2 Variant Detection in Wastewater
IRVINE, Calif., May 11, 2021 /PRNewswire/ -- Zymo Research has released the VirSieve™ Bioinformatics Pipeline source code to the environmental microbiology community to promote global collaboration and support for the detection of SARS-CoV-2 variants in wastewater. VirSieve™ is an automated compu...
2021-05-11 17:05
2881
Seegene's Germany subsidiary supports the back-to-school initiative with its COVID-19 tests
* SEEGENE BACKS GERMANY IN ITS EFFORT TO RETURN TO NORMALCY * GERMAN SUBSIDIARY TO SUPPLY COVID-19 DIAGNOSTIC TESTS ENOUGH TO TEST 734,000 PUPILS SEOUL, South Korea, May 11, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading molecular diagnostics firm said its German subsidiary, Seegene...
2021-05-11 10:11
1883
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate
- Manuscript highlights development of robust responses to both influenza and COVID-19 and protection against the SARS-CoV-2 virus - Data shared via preprint server for biology, bioRxiv, ahead of publication GAITHERSBURG, Md., May 10, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...
2021-05-10 21:55
4645
Hong Kong Government Endorses INDICAID® in Visitation Resumption Arrangements
HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...
2021-05-10 09:36
3942
Aaseya Receives the Client Innovation Award for Social Responsibility from Pega
HYDERABAD, India, May 8, 2021 /PRNewswire/ -- Aaseya, Pega Gold Partner,
received the Client Innovation Award for Social Responsibility from Pegasystems
atPegaWorld iNspire 2021
2021-05-08 01:47
4063
UserTesting Research Finds Australians Express Caution Regarding Travel Bubble, and For Good Reason
SYDNEY, May 7, 2021 /PRNewswire/ -- Optimism abounded for many Australian
tourists when a travel bubble betweenAustralia and New Zealand, allowing travel
without quarantine, opened onApril 18th. UserTesting
2021-05-07 16:47
2583
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
SEATTLE, May 6, 2021 /PRNewswire/ -- Globally, COVID-19 has caused approximately 6.9 million deaths, more than double what official numbers show, according toa new analysis by the Institute for Health Metrics and Evaluation (IHME) at theUniversity of Washington School of Medicine. IHME found that...
2021-05-06 23:00
3780
Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility
* Novavax to deliver 350 million doses beginning Q3 2021 * 1.1 billion doses of Novavax vaccine to be available to countries participating in COVAX * Serum Institute of India to provide balance of doses for LMICs * Underscores commitment to global equitable access to Novavax vaccine GAITHE...
2021-05-06 21:53
5848
Zero-Contact Medical Station for a Safe and Rapid PCR Covid-19 Testing
HSINCHU, May 6, 2021 /PRNewswire/ -- Brain Navi Biotechnology Co., Ltd., a brain surgery robotic company, is launching "zero-contact" medical stations in hospitals across Taiwan, fully protect medical staff and patients from the cross-infection of "highly contagious diseases." The biggest risk of...
2021-05-06 15:39
2966
Lam Research Commits $1 Million to Battle Against COVID-19 in India
BANGALORE, India, May 6, 2021 /PRNewswire/ -- Lam Research today announced it
will donate$1 million (~7.5 cr INR) for COVID-19 relief and recovery efforts in
India. The funds will support both local efforts in Bangalore and the Direct
Relief
2021-05-06 13:30
4221
Ortho Clinical Diagnostics Launches Quantitative COVID-19 IgG Antibody Test with CE Mark
- Ortho's VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is developed to facilitate the standardization of SARS-CoV-2 serological methods - The test gives clinicians and public health leaders a standa...
2021-05-05 20:00
3451
CSafe Global Providing Thermal Protection for COVID-19 Vaccine Shipments from BioNTech Facility
The tailor-made double-wall VIP insulated shipper provides 10+ days of temperature protection for vaccine shipments from BioNTech's facility with minimal dry ice. DAYTON, Ohio, May 5, 2021 /PRNewswire/ -- CSafe Global, the innovation leader in active, passive parcel and cell and gene temperature...
2021-05-05 20:00
4313
Week's Top Stories
Most Reposted
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 277 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 262 media titles]
2025-12-29 18:53CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 259 media titles]
2025-12-29 09:00
"Nihao China" App Launches as an All-in-One Solution for International Visitors
[Picked up by 253 media titles]
2025-12-24 17:54